Jonathan Wang, PhD, MBA

Dr. Wang is the founder of Inmagene and served as its Chairman of the Board of Directors and Chief Executive Officer from July 2019 to the closing of Inmagene’s merger with Ikena Oncology. Dr. Wang has more than 30 years of healthcare and life sciences experience, spanning entrepreneurship, investment, and research. Previously, he was a healthcare investor for 22 years. For 12 years, Dr. Wang was a Partner at OrbiMed and a co-founder at OrbiMed Asia, where he worked with his partners to establish and manage US$1.1 billion of private equity and venture capital funds. Under the supervision of Eric Kandel, a Nobel laureate, Dr. Wang obtained his Ph.D. in Neurobiology from Columbia University where he was rewarded the Howard Hughes Medical Institute Research Fellowship. Dr. Wang has also obtained an MBA from Stanford University and a B.S. in Biology from Wuhan University in China. Dr. Wang is a co-founder and former Chairman of the BayHelix Group and has authored two philosophy of science books. We believe that Dr. Wang is qualified to serve as a member of the combined company’s board of directors because of his extensive experience in the healthcare and life sciences sectors, including his experience as Inmagene’s Chief Executive Officer, his proven track record in entrepreneurship and investment, and his strong academic background.